CA2091690A1 - Composes tricycliques de substitution - Google Patents

Composes tricycliques de substitution

Info

Publication number
CA2091690A1
CA2091690A1 CA002091690A CA2091690A CA2091690A1 CA 2091690 A1 CA2091690 A1 CA 2091690A1 CA 002091690 A CA002091690 A CA 002091690A CA 2091690 A CA2091690 A CA 2091690A CA 2091690 A1 CA2091690 A1 CA 2091690A1
Authority
CA
Canada
Prior art keywords
group
compound
carbon
nitrogen atom
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002091690A
Other languages
English (en)
Inventor
Siegfried H. Reich
Mary A. M. Fuhry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agouron Pharmaceuticals LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2091690A1 publication Critical patent/CA2091690A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002091690A 1990-09-25 1991-09-25 Composes tricycliques de substitution Abandoned CA2091690A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58766690A 1990-09-25 1990-09-25
US587,666 1990-09-25

Publications (1)

Publication Number Publication Date
CA2091690A1 true CA2091690A1 (fr) 1992-03-26

Family

ID=24350713

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091690A Abandoned CA2091690A1 (fr) 1990-09-25 1991-09-25 Composes tricycliques de substitution

Country Status (10)

Country Link
EP (1) EP0550589A1 (fr)
JP (1) JPH06503814A (fr)
CN (1) CN1062908A (fr)
AU (1) AU8628791A (fr)
CA (1) CA2091690A1 (fr)
IL (1) IL99551A0 (fr)
MX (1) MX9101228A (fr)
WO (1) WO1992005173A1 (fr)
YU (1) YU155791A (fr)
ZA (1) ZA917613B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003439A1 (fr) * 1992-07-29 1994-02-17 Agouron Pharmaceuticals, Inc. Composes tricycliques a activite antiproliferatrice
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US7524635B2 (en) 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
CN101160312A (zh) * 2005-04-14 2008-04-09 霍夫曼-拉罗奇有限公司 三环吡咯衍生物、它们的制备和作为药剂的应用
KR101589551B1 (ko) 2005-07-15 2016-02-02 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
NZ580802A (en) 2007-05-10 2012-09-28 Albany Molecular Res Inc Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB201005511D0 (en) * 2010-03-31 2010-05-19 Takeda Pharmaceutical Compounds and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365763A1 (fr) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Composés cycliques antiproléfératifs

Also Published As

Publication number Publication date
AU8628791A (en) 1992-04-15
IL99551A0 (en) 1992-08-18
YU155791A (sh) 1994-01-20
ZA917613B (en) 1992-08-26
WO1992005173A1 (fr) 1992-04-02
EP0550589A1 (fr) 1993-07-14
JPH06503814A (ja) 1994-04-28
MX9101228A (es) 1992-05-04
CN1062908A (zh) 1992-07-22

Similar Documents

Publication Publication Date Title
KR101300831B1 (ko) 이미다조[1,2-ａ]피리딘 유도체, 이의 제조 방법 및 그의약학적 용도
AU707707B2 (en) Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids
IE921710A1 (en) Tricyclic polyhydroxylic tyrosine kinase inhibitors
GB2123825A (en) Carbostyril derivatives
KR20140023341A (ko) 항신생물제로서의3- 및 4환성 피라졸로[3,4-b]피리딘 화합물
JP2003518475A (ja) カルボン酸アミド、その化合物を含有する医薬組成物、その使用及び調製
JP2024524766A (ja) Ｒｎａヘリカーゼｄｈｘ３３を阻害する多環式化合物及びその応用
EP0132764B1 (fr) Composés dérivés de dihydrodibenzocycloheptylidène-éthylamine
CA2091690A1 (fr) Composes tricycliques de substitution
PL122965B1 (en) Process for preparing novel, condensed derivatives of pyrimidine
AU2019260217B2 (en) Formamide compound, preparation method therefor and application thereof
KR19990023859A (ko) 치환 퀴놀론 유도체 및 이를 함유하는 의약
CN114105984A (zh) 吲哚嗪类抗蚀剂的制备方法
US4996213A (en) Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions
CN109280032B (zh) 一种哒嗪酮母核结构的组蛋白去乙酰化酶抑制剂及其制备方法和用途
TW202035406A (zh) 作為cdk-hdac雙通路抑制劑的雜環化合物
EP0366006B1 (fr) Ethers de pyridylcétoximes et compositions pharmaceutiques les contenant
KR950008313B1 (ko) 복소환 화합물 및 항궤양제
US4091095A (en) Phosphinyl compounds
IE51151B1 (en) 2-guanidinothiazole derivatives
US6310207B1 (en) Process of preparing camptothecin derivatives
US9562051B2 (en) Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer
US4452982A (en) Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them
HU187471B (en) Process for preparing n-acyl-triptamine derivatives and pharmaceutical compositions containing them as active agents
CA1153371A (fr) Methode de preparation de 9-hydrazono-6,7,8,9- tetrahydro-4h-pyro[1,2-alpyrimidine-4-ones]; leurs sels et hydrates; certains composes ainsi prepares et preparations pharmaceutiques qui en renferment

Legal Events

Date Code Title Description
FZDE Discontinued